Decreased bone mass and bone elasticity in mice lacking the transforming growth factor-beta1 gene.

[1]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[2]  A. Hata,et al.  TGF-β signalling through the Smad pathway , 1997 .

[3]  A. Kulkarni,et al.  Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expression. , 1996, The Journal of clinical investigation.

[4]  G. Mundy,et al.  Estrogen promotes apoptosis of murine osteoclasts mediated by TGF–β , 1996, Nature Medicine.

[5]  A. Roberts,et al.  Transforming growth factor‐β1–deficient mice: identification of isoform‐specific activities in vivo , 1996, Journal of leukocyte biology.

[6]  L. Donahue,et al.  Genetic variability in adult bone density among inbred strains of mice. , 1996, Bone.

[7]  R. Derynck,et al.  Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype , 1996, The Journal of cell biology.

[8]  M. Yin,et al.  Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte mediated. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[9]  M. Ferguson,et al.  Transforming growth factor–β3 is required for secondary palate fusion , 1995, Nature Genetics.

[10]  A. Geiser,et al.  SLE-like autoantibodies and Sjögren's syndrome-like lymphoproliferation in TGF-beta knockout mice. , 1995, Journal of immunology.

[11]  K. Miyazono,et al.  Localization of transforming growth factor-beta type I and type II receptors in mouse development. , 1995, Experimental cell research.

[12]  V. Rosen,et al.  Independent changes in type I and type II receptors for transforming growth factor beta induced by bone morphogenetic protein 2 parallel expression of the osteoblast phenotype , 1995, Molecular and cellular biology.

[13]  G. Mbalaviele,et al.  Short‐term local injections of transforming growth factor‐β1 decrease ovariectomy‐stimulated osteoclastic resorption in vivo in rats , 1995 .

[14]  E H Burger,et al.  Mechanical loading stimulates the release of transforming growth factor‐β activity by cultured mouse calvariae and periosteal cells , 1995, Journal of cellular physiology.

[15]  D. Simmons,et al.  Rat tail suspension reduces messenger RNA level for growth factors and osteopontin and decreases the osteoblastic differentiation of bone marrow stromal cells , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  Lynda F. Bonewald,et al.  Role of active and latent transforming growth factor β in bone formation , 1994 .

[17]  M. Sporn,et al.  Maternal rescue of transforming growth factor-beta 1 null mice. , 1994, Science.

[18]  S. Vukicevic,et al.  Opposite effects of osteogenic protein and transforming growth factor β on chondrogenesis in cultured long bone rudiments , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  S. Miller,et al.  Systemic administration of recombinant transforming growth factor beta 2 (rTGF-beta 2) stimulates parameters of cancellous bone formation in juvenile and adult rats. , 1994, Bone.

[20]  S A Goldstein,et al.  Osteoporosis induced in mice by overproduction of interleukin 4. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  M. Sporn,et al.  Transforming growth factor beta 1 (TGF-beta 1) controls expression of major histocompatibility genes in the postnatal mouse: aberrant histocompatibility antigen expression in the pathogenesis of the TGF-beta 1 null mouse phenotype. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[22]  M. Sporn,et al.  Transforming growth factor beta 1 null mutation in mice causes excessive inflammatory response and early death. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Proetzel,et al.  Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease , 1992, Nature.

[24]  S. Schreiber.  Immunophilin-sensitive protein phosphatase action in cell signaling pathways , 1992, Cell.

[25]  B. Thorp,et al.  Transforming growth factor-beta 1, -beta 2 and -beta 3 in cartilage and bone cells during endochondral ossification in the chick. , 1992, Development.

[26]  E. Amento,et al.  Rapid publication TGF‐β1 induces bone closure of skull defects , 1991 .

[27]  J. Milner,et al.  Evidence that FK506 and rapamycin block T cell activation at different sites relative to early reversible phosphorylation involving the protein phosphatases PP1 and PP2A. , 1991, Transplantation.

[28]  M E Bolander,et al.  Transforming growth factor-beta and the initiation of chondrogenesis and osteogenesis in the rat femur , 1990, The Journal of cell biology.

[29]  G. Stein,et al.  Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix , 1990, Journal of cellular physiology.

[30]  M. Sporn,et al.  Peptide Growth Factors and Their Receptors I , 1990, Handbook of Experimental Pharmacology.

[31]  J. Aubin,et al.  Effects of transforming growth factor β and epidermal growth factor on cell proliferation and the formation of bone nodules in isolated fetal rat calvaria cells , 1989 .

[32]  M. Noda,et al.  In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.

[33]  E. Canalis,et al.  Skeletal tissue and transforming growth factor β , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  M. Sporn,et al.  Some recent advances in the chemistry and biology of transforming growth factor-beta , 1987, The Journal of cell biology.

[35]  R. Derynck,et al.  Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[36]  S. K. Maiti,et al.  TRANSFORMING GROWTH FACTOR BETA (TFG-BETA ) IN BONE REMODELLING , 1996 .

[37]  J. Massagué,et al.  Serine/threonine kinase receptors: mediators of transforming growth factor beta family signals. , 1996, Cancer surveys.

[38]  R. Recker,et al.  Elastic properties of osteoporotic bone measured by scanning acoustic microscopy. , 1995, Bone.

[39]  K. Miyazono,et al.  Serine/threonine kinase receptors. , 1994, Progress in growth factor research.

[40]  P. Kondaiah,et al.  Embryonic gene expression patterns of TGF beta 1, beta 2 and beta 3 suggest different developmental functions in vivo. , 1991, Development.

[41]  G. Mundy,et al.  The effects of TGF-beta on bone. , 1991, Ciba Foundation symposium.

[42]  L. Bonewald,et al.  Role of transforming growth factor-beta in bone remodeling. , 1990, Clinical orthopaedics and related research.

[43]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.